Novavax (XBUL:NVV1) Other Long Term Assets : лв38 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Novavax Other Long Term Assets?

Novavax's other long-term assets for the quarter that ended in Mar. 2025 was лв38 Mil.

Novavax's quarterly other long-term assets declined from Sep. 2024 (лв53 Mil) to Dec. 2024 (лв41 Mil) but then stayed the same from Dec. 2024 (лв41 Mil) to Mar. 2025 (лв38 Mil).

Novavax's annual other long-term assets increased from Dec. 2022 (лв49 Mil) to Dec. 2023 (лв61 Mil) but then declined from Dec. 2023 (лв61 Mil) to Dec. 2024 (лв41 Mil).

Novavax Other Long Term Assets Historical Data

The historical data trend for Novavax's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Other Long Term Assets Chart

Novavax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

22.76

41.82

49.01

60.53

41.32

Novavax Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															53.31	58.24	52.59	41.32	37.71

Novavax Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Novavax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (XBUL:NVV1) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany NVAX:Austria

Address

700 Quince Orchard Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Novavax Headlines

No Headlines